OVULATION INHIBITORS.
One hundred and eighty-five women were followed up for periods up to 15 months (a total of 964 menstrual cycles) to determine the contraceptive efficacy and side effects of 2 mg. norethindrone with 0.1 mg. mestranol, as well as other therapeutic benefits. No pregnancies occurred in those using this method alone for contraception. Side effects were minimal. This low dosage was also useful in the management of dysmenorrhea, menorrhagia and irregular menses.
D003267:Contraception; D003270:Contraceptive Agents; D003276:Contraceptives, Oral; D004412:Dysmenorrhea; D005260:Female; D006801:Humans; D008599:Menstruation Disturbances; D008656:Mestranol; D009640:Norethindrone; D034445:Ovulation Inhibition; D014116:Toxicology
D003270:Contraceptive Agents; D003276:Contraceptives, Oral; D008656:Mestranol; D009640:Norethindrone
CONTRACEPTIVES, ORAL; MENSTRUATION DISORDERS; MESTRANOL; NORETHINDRONE; TOXICOLOGIC REPORT